Albireo to Showcase New Data at AASLD The Liver Meeting®
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable efficacy in patients...
Source: globenewswire.com
Page 3 - Test Abnormalities News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Test Abnormalities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Test Abnormalities Today - Breaking & Trending Today
Albireo Pharma, Inc.: Italian Medicines Agency Approves Reimbursed Access to Bylvay (odevixibat) For Patients with All PFIC Types
Positive Agenzia Italiana del Farmaco (AIFA) decision provides reimbursed access to the first medicine available for the treatment of all types of PFIC, a rare and devastating disorder that affects
Source: finanznachrichten.de
Albireo Appoints New Members to Board of Directors
– Habib Dable, Former President and CEO of Acceleron Pharma, and Susan Alesina, Vice President, National Business Development and Alliances at Boston...
Source: globenewswire.com
Albireo Presents New Bylvay® (odevixibat) Data at Annual ESPGHAN Congress
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com